View Sample PDF

The purpose of this report is to analyze and describe the nuclear cardiology market segments in the U.S. and worldwide. It examines the measurement devices that are utilized by physicians to diagnose and monitor heart diseases. This study also discusses key products in nuclear cardiology and examines the trends that are stimulating this market. It includes a survey of all major companies actively engaged in marketing, manufacturing or developing nuclear cardiological instrumentation, with each company discussed in depth. The main objectives of this analysis are to:

• Identify viable technology drivers through a comprehensive look at platform technologies for nuclear cardiology testing.

• Obtain a complete understanding of the individual nuclear cardiology testing platforms from their basic principles to their clinical applications.

• Discover feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas.

• Focus on global industry developments through an in-depth analysis of the major world markets for nuclear cardiology technology, including growth forecasts.

• Present market figures related to the current value of nuclear cardiology, market projections, market share, key players, and sector growth rates.

An analysis of the nuclear cardiology market must include several key areas of related activity. The most important segments discussed in this report include:

• Hardware (e.g., nuclear cardiology instrumentation).
• Software (e.g., nuclear cardiology image processing, PACS).
• Radiopharmaceuticals and pharmaceuticals.
• Ancillary products.
• Service and support.

1. 1. Overview 5
2. 1.1 Objectives 5
3. 1.2 Scope 6
4. 1.3 Methodology 6
5. 1.4 Executive Summary 6
7. 2. Medical Imaging Market Analysis 10
8. 2.1 Medical Imaging Industry Market Size 10
9. 2.2 Medical Imaging Infrastructure 11
10. 2.2.1 Total Healthcare Expenditures and Demographics 11
11. 2.2.2 Number of Hospitals 12
12. 2.2.3 Number of Radiologists 13
13. 2.2.4 Radiology Services 14
14. 2.2.5 Medical Imaging Companies 16
15. 2.2.6 Market Drivers 16
16. 2.2.6.1 Product Enhancements 17
17. 2.2.6.2 Contrast Agents Development 17
18. 2.2.6.3 Innovation 17
19. 2.2.7 Market Restraints 18
20. 2.2.8 Market Segments for Medical Imaging 18
21. 2.2.8.1 Discovery 18
22. 2.2.8.2 Clinical Applications 19
23. 2.2.8.3 Clinical Trials 19
24. 2.2.8.4 Outpatient Facilities 19
25. 2.2.8.5 Technology Advances in Diagnostic Imaging Modalities 19
26. 2.2.8.6 Safety and Ergonomics Concerns 19
27. 2.2.8.7 Volumetric Imaging 20
28. 2.2.8.8 Digital Radiography (DR) 20
29. 2.2.8.9 Contrast Media 21
31. 3. Nuclear Medicine and Nuclear Cardiology Market 29
32. 3.1 Medical Imaging Industry Forecasts 29
33. 3.2 Hardware Companies (Nuclear Medicine Instrumentation) 30
34. 3.3 Software Companies (Image Processing and PACS) 30
35. 3.4 Radiopharmaceuticals and Pharmaceuticals Companies 31
36. 3.5 Ancillary Products Companies 31
37. 3.6 Service and Support Companies 31
38. 3.7 Nuclear Cardiology Market 31
39. 3.8 Hardware (PET, SPECT and Hybrids) 33
40. 3.8.1 Scanner Investment: Not Just a Cardiology Market 33
41. 3.8.1.1 Impact of Alzheimer's Reimbursement 34
42. 3.8.2 Sales Trends for PET Scanners 34
43. 3.8.3 Market Consolidation in the U.S. 34
44. 3.8.4 Learning Curve Impact for PET 35
45. 3.8.5 Hardware Market Trends 35
46. 3.9 Software (PACS and RIS) 36
47. 3.10 Radiopharmaceuticals 37
48. 3.10.1 Diagnostic Radiopharmaceuticals 37
49. 3.10.2 Therapeutic Radiopharmaceuticals 37
51. 4. Products Analysis 38
52. 4.1 Nuclear Medicine Instrumentation 38
53. 4.1.1 PET Scan 38
54. 4.1.2 SPECT Scan 39
55. 4.1.2.1 Heart Imaging 41
56. 4.1.3 PET Versus SPECT 42
57. 4.1.4 Hybrid Technology 42
58. 4.2 Image Processing: PACS 46
59. 4.2.1 PACS and Nuclear Medicine 46
60. 4.2.2 Difficulties in Making PACS Work with Nuclear Medicine 46
61. 4.2.1.2 3-D and Quantitative Analysis 47
62. 4.2.1.5 Small Market Opportunities 47
63. 4.3 Radiopharmaceuticals and Pharmaceuticals 47
64. 4.3.1 Introduction 47
65. 4.3.2 Background 48
66. 4.3.3 Areas of Current Interest 49
68. 5. Regulations, Reimbursements and Other Issues 50
69. 5.1 Food and Drug Administration (FDA) 50
70. 5.1.1 FDA Guidance 50
71. 5.1.2 FDA Nuclear Medicine Coalition 50
72. 5.2 U.S. Nuclear Regulatory Commission (NRC) 50
73. 5.2.1 What NRC Regulates 50
74. 5.2.2 How NRC Regulates 51
75. 5.2.3 Related Information 51
76. 5.3 Memorandum of Understanding between NRC and FDA 51
77. 5.3.1 Authorities and Regulatory Programs 51
78. 5.4 Current NRC Issues and Actions 54
79. 5.4.1 Meetings 54
80. 5.4.2 Program and Policy Issues 54
81. 5.4.3 Recently Issued Significant Enforcement Actions 55
82. 5.4.3.1 Stark II Regulations 55
83. 5.4.3.2 Recent Impact of Stark II Regulations 56
84. 5.4.3.3 Reimbursement 56
86. 6. Business Affairs (Mergers, Acquisitions and Partnerships) 57
87. 6.1 Recent Corporate Partnerships and Mergers 57
88. 6.2 Recent Industry Activity 57
89. 6.3 Product Launches and Developments 58
91. 7. Technology Trends 60
92. 7.1 Hardware (Nuclear Medicine Instrumentation) 60
93. 7.2 Software (PACS) 63
94. 7.2.1 Problems Interfacing PACS and NM 64
95. 7.2.2 SNM and IHE 64
96. 7.2.3 IHE Nuclear Medicine Profile 64
97. 7.2.4 What Next? 65
98. 7.2.5 Optimal Patient Care 66
99. 7.2.6 Four Steps to Standards Adoption 66
100. 7.2.7 Technical Framework: Business with Technology 67
101. 7.2.8 Leading by Example 68
102. 7.2.9 IHE and Electronic Health Record (EHR) 68
103. 7.3 Radiopharmaceuticals and Pharmaceuticals 68
104. 7.3.1 Market Share 69
105. 7.3.2 Contrast Media Market Drivers 70
106. 7.3.3 Contrast Media Market Sector Overview 70
107. 7.3.4 Contrast Media Market Analysis 71
108. 7.3.5 Growth Prospects for Contrast Media 71
109. 7.4 Market Sector Analysis 71
110. 7.5 Leading Companies in General Medical Imaging 73
112. 8. Company Profiles 74
113. 8.1 Hardware (Nuclear Medicine Instrumentation) 74
114. 8.1.1 AccuSync Medical Research 74
115. 8.1.2 Bristol-Myers Squibb (Medical Imaging) 74
116. 8.1.3 Capintec 75
117. 8.1.4 CardiArc 75
118. 8.1.5 Cardinal Health (Cardiology Solutions) 75
119. 8.1.6 Digirad 76
120. 8.1.7 GE Healthcare 76
121. 8.1.8 GVI Medical Devices 77
122. 8.1.9 Hitachi Medical Systems America 78
123. 8.1.10 IS2 Medical Systems 79
124. 8.1.11 Mediso 79
125. 8.1.12 Philips Medical 80
126. 8.1.13 Positron 81
127. 8.1.14 Siemens Medical 81
128. 8.1.15 Spectrum Dynamics 82
129. 8.2 Software (Image Processing and PACS) 83
130. 8.2.1 Heartlab 83
131. 8.2.2 Hermes Medical Solutions 84
132. 8.2.3 INVIA 84
133. 8.2.4 McKesson 85
134. 8.2.5 MedImage 85
135. 8.2.6 MIMvista 85
136. 8.2.7 Numa 86
137. 8.2.8 ProSolv Cardiovascular 86
138. 8.2.9 Scientific Imaging 86
139. 8.2.10 Segami Corporation 86
140. 8.2.11 Syntermed 86
141. 8.2.12 Thinking Systems Corporation 87
142. 8.2.13 UltraSPECT 87
143. 8.2.14 Witt Biomedical Corporation 87
144. 8.3 Radiopharmaceuticals and Pharmaceuticals 87
145. 8.3.1 Astellas Pharma U.S. 87
146. 8.3.2 Bracco Diagnostics 88
147. 8.3.3 Isotope Products Laboratories 88
148. 8.3.4 Izotop: Institute of Isotopes 89
149. 8.3.5 Mallinckrodt 89
150. 8.3.6 Merck 89
151. 8.3.7 NuView Radiopharmaceuticals 91
152. 8.3.8 Pfizer 91
153. 8.3.9 Tyco Healthcare 91
154. 8.4 Ancillary Products 92
155. 8.4.1 CNMTStore.com 92
156. 8.4.2 Data Spectrum Corporation 92
157. 8.4.3 Daxor Corporation 93
158. 8.4.4 Ivy Biomedical Systems 93
159. 8.4.5 MarCal Medical 93
160. 8.5 Service and Support 93
161. 8.5.1 BC Technical 93
162. 8.5.2 Diagnostix Plus 94
163. 8.5.3 MedAxiom 94
164. 8.5.4 MediNuclear Corporation (MNC) 94
165. 8.5.5 MEDX 94
166. 8.5.6 Pinestar Technology 95
167. 8.5.7 Technology Imaging Services 95
168. 8.6 Other Business Opportunities 95
170. 9. Other Elements of Nuclear Medicine Industry 96
171. 9.1 Nuclear Medicine: Guidelines, Certification and Societies 96
172. 9.1.1 American College of Radiology (ACR) 96
173. 9.1.2 American Society of Nuclear Cardiology (ASNC) 96
174. 9.1.3 Associates in Medical Physics (AMP) 96
175. 9.1.4 Certification Board of Nuclear Cardiology (CBNC) 96
176. 9.1.5 ICANL 97
177. 9.1.6 IHE 97
178. 9.1.7 ISO 97
179. 9.1.8 MedPage Today 97
180. 9.1.9 Nuclear Medicine Technology Certification Board (NMTCB) 97
181. 9.1.10 Society of Cardiovascular Computed Tomography (SCCT) 98
182. 9.1.11 Society of Nuclear Medicine (SNM) 98
183. 9.2 Nuclear Medicine: Publications 98
184. 9.2.1 Elsevier 98
185. 9.2.2 HRA Research 99
186. 9.2.3 Lippincott Williams & Wilkins 99
189. INDEX OF FIGURES
191. Figure 3.1: U.S. Nuclear Imaging Procedures 32
192. Figure 3.2: Digirad--Growth of Nuclear Imaging Procedures, 2004-2006 32
193. Figure 4.1: Nuclear Imaging 38
194. Figure 4.2: PET Scan 39
195. Figure 4.3: SPECT Scan 40
196. Figure 4.4: PET-CT Scan 43
197. Figure 4.5: SPECT-CT Scan 45
198. Figure 7.1: IHE Technical Framework 66
199. Figure 7.2: IHE Framework Organization 67
200. Figure 7.3: IHE Actors and Transactions 68
203. INDEX OF TABLES
205. Table 2.1: U.S. Medical Imaging Market Size, 2001-2010 10
206. Table 2.2: Global Medical Imaging Market Size, 2001-2010 10
207. Table 2.3: U.S. Health Expenditures as a Percentage of GDP, 2000-2010 11
208. Table 2.4: U.S. User Expenditures for Medical Imaging Equipment and Related Products 11
209. Table 2.5: Millions of Americans Over 65 Years of Age, 2000-2050 12
210. Table 2.6: Hospital Survey 12
211. Table 2.7: Percent Change in Volume of Examinations per Imaging Modality, 1993-2004 15
212. Table 2.8: Worldwide Market Share of Medical Imaging Companies 16
213. Table 2.9: Worldwide Imaging Procedures, 2001 to 2010 22
214. Table 2.10: Data Sources for Nuclear Medicine Professionals and Facilities 27
215. Table 7.1: Market Share of Contrast Media Players 69
216. Table 7.2: Contrast Media Market Growth, 2003-2010 70
217. Table 7.3: Worldwide Imaging Procedures, 2001-2010 72
218. Table 8.1: Astellas Alliances 88